Inglês

Sample ID, body site where sample was collected of participants with or without angioedema and involved in the "A Genome-Wide Association Analysis in Angiotensin-Converting enzyme (ACE) Inhibitor-Associated Angioedema and ACE Inhibitor-Exposed Controls; A Collaboration between the NIH Pharmacogenomics Research Network and the RIKEN Yokohama Center for Genomic Medicine" project.

5 Formulários  
  1. StudyEvent: dbGaP phs000438 PGRN-RIKEN: Identification of Genetic Predictors of ACE Inhibitor-Associated Angioedema
    1. Eligibility Criteria
    2. Subject ID, consent group, and affection status of participants with or without angioedema and involved in the "A Genome-Wide Association Analysis in Angiotensin-Converting enzyme (ACE) Inhibitor-Associated Angioedema and ACE Inhibitor-Exposed Controls; A Collaboration between the NIH Pharmacogenomics Research Network and the RIKEN Yokohama Center for Genomic Medicine" project.
    3. Subject ID, sample ID, and sample use of participants with or without angioedema and involved in the "A Genome-Wide Association Analysis in Angiotensin-Converting enzyme (ACE) Inhibitor-Associated Angioedema and ACE Inhibitor-Exposed Controls; A Collaboration between the NIH Pharmacogenomics Research Network and the RIKEN Yokohama Center for Genomic Medicine" project.
    4. Subject ID, case or control, age, gender, and race of participants with or without angioedema and involved in the "A Genome-Wide Association Analysis in Angiotensin-Converting enzyme (ACE) Inhibitor-Associated Angioedema and ACE Inhibitor-Exposed Controls; A Collaboration between the NIH Pharmacogenomics Research Network and the RIKEN Yokohama Center for Genomic Medicine" project.
    5. Sample ID, body site where sample was collected of participants with or without angioedema and involved in the "A Genome-Wide Association Analysis in Angiotensin-Converting enzyme (ACE) Inhibitor-Associated Angioedema and ACE Inhibitor-Exposed Controls; A Collaboration between the NIH Pharmacogenomics Research Network and the RIKEN Yokohama Center for Genomic Medicine" project.
pht003321
Descrição

pht003321

De-identified sample ID
Descrição

SAMPLE_ID

Tipo de dados

string

Alias
UMLS CUI [1,1]
C2346787
UMLS CUI [1,2]
C2348585
Body site where sample was collected
Descrição

BODY_SITE

Tipo de dados

string

Alias
UMLS CUI [1,1]
C1545955
UMLS CUI [1,2]
C0200345
Analyte type
Descrição

ANALYTE_TYPE

Tipo de dados

string

Alias
UMLS CUI [1,1]
C4744818
Tumor status
Descrição

IS_TUMOR

Tipo de dados

text

Alias
UMLS CUI [1,1]
C0475752
Voltar ao início da página

Similar models

Sample ID, body site where sample was collected of participants with or without angioedema and involved in the "A Genome-Wide Association Analysis in Angiotensin-Converting enzyme (ACE) Inhibitor-Associated Angioedema and ACE Inhibitor-Exposed Controls; A Collaboration between the NIH Pharmacogenomics Research Network and the RIKEN Yokohama Center for Genomic Medicine" project.

5 Formulários
  1. StudyEvent: dbGaP phs000438 PGRN-RIKEN: Identification of Genetic Predictors of ACE Inhibitor-Associated Angioedema
    1. Eligibility Criteria
    2. Subject ID, consent group, and affection status of participants with or without angioedema and involved in the "A Genome-Wide Association Analysis in Angiotensin-Converting enzyme (ACE) Inhibitor-Associated Angioedema and ACE Inhibitor-Exposed Controls; A Collaboration between the NIH Pharmacogenomics Research Network and the RIKEN Yokohama Center for Genomic Medicine" project.
    3. Subject ID, sample ID, and sample use of participants with or without angioedema and involved in the "A Genome-Wide Association Analysis in Angiotensin-Converting enzyme (ACE) Inhibitor-Associated Angioedema and ACE Inhibitor-Exposed Controls; A Collaboration between the NIH Pharmacogenomics Research Network and the RIKEN Yokohama Center for Genomic Medicine" project.
    4. Subject ID, case or control, age, gender, and race of participants with or without angioedema and involved in the "A Genome-Wide Association Analysis in Angiotensin-Converting enzyme (ACE) Inhibitor-Associated Angioedema and ACE Inhibitor-Exposed Controls; A Collaboration between the NIH Pharmacogenomics Research Network and the RIKEN Yokohama Center for Genomic Medicine" project.
    5. Sample ID, body site where sample was collected of participants with or without angioedema and involved in the "A Genome-Wide Association Analysis in Angiotensin-Converting enzyme (ACE) Inhibitor-Associated Angioedema and ACE Inhibitor-Exposed Controls; A Collaboration between the NIH Pharmacogenomics Research Network and the RIKEN Yokohama Center for Genomic Medicine" project.
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
pht003321
SAMPLE_ID
Item
De-identified sample ID
string
C2346787 (UMLS CUI [1,1])
C2348585 (UMLS CUI [1,2])
BODY_SITE
Item
Body site where sample was collected
string
C1545955 (UMLS CUI [1,1])
C0200345 (UMLS CUI [1,2])
ANALYTE_TYPE
Item
Analyte type
string
C4744818 (UMLS CUI [1,1])
Item
Tumor status
text
C0475752 (UMLS CUI [1,1])
IS_TUMOR
Code List
Tumor status
CL Item
Is not a tumor (N)
CL Item
Is Tumor (Y)
Voltar ao início da página